Werkgroep Cardiologische centra Nederland English

DELIVER (Includerend)

An International, Double-blind, Randomised Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Morbidity and Mortality in Patients with HFpEF
Middel
dapagliflozin
Populatie
hartfalen
Fase
III
Jaar aanvang
2017